RecruitingEarly Phase 1NCT06613490

An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis

Studying Antisynthetase syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The First Affiliated Hospital with Nanjing Medical University
Intervention
anti CD19 CAR NK cells(biological)
Enrollment
24 enrolled
Eligibility
18-70 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Collaborators

Rui Therapeutics Co., Ltd

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06613490 on ClinicalTrials.gov

Other trials for Antisynthetase syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antisynthetase syndrome →

← Back to all trials